TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function

Authors:

Abstract
No abstract available
Funding Information
  • Amgen (Amgen Inc.) (Discovery research)

This publication has 37 references indexed in Scilit: